Subscribe To
OCEA / Why Is Ocean Biomedical (OCEA) Stock Up 26% Today?
OCEA News
By Seeking Alpha
August 28, 2023
Ocean Biomedical: Some New Targets, No Clinical Data. Not For Me
Ocean Biomedical is a biotech company focused on generating lead candidates for clinical development. They have programs in various therapeutic areas, more_horizontal
By GlobeNewsWire
August 1, 2023
Ocean Biomedical, Inc. (NASDAQ: OCEA) Celebrates 95% Lung Cancer Tumor Reduction Results on World Lung Cancer Day
Ocean Biomedical's Oncology Platform currently consists of 27 Patents Issued or Pending. Ocean Biomedical's first-in-class anti-CHi3L1 therapeutic imm more_horizontal
By InvestorPlace
June 21, 2023
Why Is Ocean Biomedical (OCEA) Stock Up 26% Today?
Ocean Biomedical (NASDAQ: OCEA ) stock is rising higher on Wednesday after the medical company announced a price target increase from Fundamental Rese more_horizontal
By InvestorPlace
May 23, 2023
Why Is Ocean Biomedical (OCEA) Stock Up 28% Today?
Ocean Biomedical (NASDAQ: OCEA ) stock skyrocketed on Tuesday on the announcement of a potentially groundbreaking development. Specifically, Ocean's s more_horizontal
By Proactive Investors
April 13, 2023
Ocean Biomedical shares soar on upcoming US patent for ‘whole new class' of malaria therapeutics
Ocean Biomedical shares added almost 50% on Thursday after the biopharma company announced it is set to receive a US patent in the coming months tha more_horizontal
By The Motley Fool
March 9, 2023
Why Shares of Ocean Biomedical Soared Thursday
Ocean Biomedical just began trading on the NASDAQ last month. The company is a clinical-stage biotech and doesn't have any marketed therapies. more_horizontal
By InvestorPlace
February 23, 2023
Why Is Ocean Biomedical (OCEA) Stock Up 260% Today?
There's a tidal wave of buying activity with Ocean Biomedical (NASDAQ: OCEA ) stock today. Why are financial traders so enthused about OCEA stock? more_horizontal